Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-08-28

Clinical Trial Update: Comparing Clinical Outcomes Between Ketamine-midazolam and Morphine-midazolam for Continous Sedation in ICU Patients. [Phase 2, Phase 3]

View source ↗

Summary

A terminated Phase 2/3 clinical trial comparing ketamine-midazolam versus morphine-midazolam for continuous sedation in critically ill ICU patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ketamine-midazolam
  • morphine-midazolam

Snippet

Sponsor: Makerere University | Conditions: Critical Illness | Phase 2, Phase 3 | Status: TERMINATED